Rekah Pharmaceutical Industry Ltd. (TLV:REKA)
Israel · Delayed Price · Currency is ILS · Price in ILA 1,141.00
-31.00 (-2.65%)
Mar 31, 2026, 5:24 PM IDT
TLV:REKA Market Cap
TLV:REKA has a market cap or net worth of 133.55 million as of March 31, 2026. Its market cap has decreased by -19.42% in one year.
Market Cap
133.55M
Enterprise Value
263.12M
Revenue
300.24M
Ranking
n/a
PE Ratio
n/a
Stock Price
1,141.00
Market Cap Chart
Since April 5, 2005, TLV:REKA's market cap has increased from 107.92M to 133.55M, an increase of 23.75%. That is a compound annual growth rate of 1.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2026 | 133.55M | 6.95% |
| Dec 31, 2025 | 124.88M | -17.43% |
| Dec 31, 2024 | 151.24M | -10.35% |
| Dec 31, 2023 | 168.71M | -3.96% |
| Dec 29, 2022 | 175.67M | -33.89% |
| Dec 30, 2021 | 265.73M | -13.13% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 104.74B |
| Danel (Adir Yeoshua) | 2.64B |
| BrainsWay | 1.72B |
| Kamada | 1.50B |
| Geffen Residence & Renewal | 266.92M |
| Epitomee Medical | 255.17M |
| Golden House | 166.65M |
| InterCure | 129.76M |